Pivotal bioVenture Partners Fund I, L.P.
SEC insider (Form 3/4/5 filer). CIK 0001695076. Director & 10% Owner at Evommune, Inc. (EVMN). 3 reported Form 4/5 transactions since Sep 2024; latest on Nov 7, 2025. Located in SAN FRANCISCO, CA.
Companies Pivotal bioVenture Partners Fund I, L.P. has filed insider reports for
- Evommune, Inc. (EVMN): Director, 10% Owner
Pivotal bioVenture Partners Fund I, L.P.
CIK: 0001695076
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)3 (100.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EVMN
Evommune, Inc.
Director10% Owner